Elixinol Wellness (ASX:EXL) Debt-to-Revenue : 0.13 (As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Elixinol Wellness Debt-to-Revenue?

Debt-to-Revenue measures a company's ability to pay off its debt.

Elixinol Wellness's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$1.07 Mil. Elixinol Wellness's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was A$0.19 Mil. Elixinol Wellness's annualized Revenue for the quarter that ended in Dec. 2023 was A$9.63 Mil. Elixinol Wellness's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 was 0.13.

Elixinol Wellness Debt-to-Revenue Historical Data

The historical data trend for Elixinol Wellness's Debt-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Elixinol Wellness Debt-to-Revenue Chart

Elixinol Wellness Annual Data

Trend

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Debt-to-Revenue

Get a 7-Day Free Trial

0.17

0.18

0.29

0.27

0.15

Elixinol Wellness Semi-Annual Data
	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-Revenue	Get a 7-Day Free Trial							0.30	0.33	0.25	0.19	0.13

Competitive Comparison of Elixinol Wellness's Debt-to-Revenue

For the Drug Manufacturers - Specialty & Generic subindustry, Elixinol Wellness's Debt-to-Revenue, along with its competitors' market caps and Debt-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Elixinol Wellness's Debt-to-Revenue Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Elixinol Wellness's Debt-to-Revenue distribution charts can be found below:

* The bar in red indicates where Elixinol Wellness's Debt-to-Revenue falls into.

Elixinol Wellness Debt-to-Revenue Calculation

Debt-to-Revenue measures a company's ability to pay off its debt.

Elixinol Wellness's Debt-to-Revenue for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.07	+	0.192)	/	8.269
	=	0.15

Elixinol Wellness's annualized Debt-to-Revenue for the quarter that ended in Dec. 2023 is calculated as

Debt-to-Revenue	=	Total Debt			/	Revenue
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Revenue
	=	(1.07	+	0.192)	/	9.628
	=	0.13

In the calculation of annual Debt-to-Revenue, the Revenue of the last fiscal year is used. In calculating the annualized quarterly data, the Revenue data used here is two times the quarterly (Dec. 2023) Revenue data.

Elixinol Wellness Debt-to-Revenue Related Terms

Thank you for viewing the detailed overview of Elixinol Wellness's Debt-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Elixinol Wellness (ASX:EXL) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Elixinol Wellness Ltd (ASX:EXL) » Definitions » Debt-to-Revenue

Comparable Companies

Traded in Other Exchanges

ELLXF:USA

Address

680 George Street, Level 12, Sydney, NSW, AUS, 2000

Website

https://www.elixinolwellness.com

Elixinol Wellness Ltd is engaged in the hemp industry, innovating, marketing, and selling hemp-derived nutraceutical, cosmetic, and food products. It operates in the geographical segments of the Americas, Australia, Europe and other regions of which key revenue is derived from the Americas segment. The Americas segment includes the trading results of Elixinol LLC (Elixinol Americas) and its investments and joint ventures in the US through the manufacture and distribution of hemp-derived cannabidiol products.

Elixinol Wellness (ASX:EXL) Headlines

No Headlines